Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - BIO-TECHNE Corpex_187167.htm
EX-31.2 - EXHIBIT 31.2 - BIO-TECHNE Corpex_187166.htm
EX-31.1 - EXHIBIT 31.1 - BIO-TECHNE Corpex_187165.htm
EX-23 - EXHIBIT 23 - BIO-TECHNE Corpex_187164.htm
EX-21 - EXHIBIT 21 - BIO-TECHNE Corpex_187163.htm
EX-10.11 - EXHIBIT 10.11 - BIO-TECHNE Corpex_200249.htm
EX-10.10 - EXHIBIT 10.10 - BIO-TECHNE Corpex_200248.htm
EX-10.9 - EXHIBIT 10.9 - BIO-TECHNE Corpex_200247.htm
EX-10.8 - EXHIBIT 10.8 - BIO-TECHNE Corpex_200246.htm
EX-10.7 - EXHIBIT 10.7 - BIO-TECHNE Corpex_200245.htm
EX-10.6 - EXHIBIT 10.6 - BIO-TECHNE Corpex_200244.htm
EX-10.5 - EXHIBIT 10.5 - BIO-TECHNE Corpex_200243.htm
EX-10.4 - EXHIBIT 10.4 - BIO-TECHNE Corpex_200242.htm
EX-10.3 - EXHIBIT 10.3 - BIO-TECHNE Corpex_200241.htm
EX-4.1 - EXHIBIT 4.1 - BIO-TECHNE Corpex_201045.htm
10-K - FORM 10-K - BIO-TECHNE Corptech20200630_10k.htm

Exhibit 32.2

 

 

BIO-TECHNE CORPORATION

 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Annual Report of Bio-Techne Corporation (the “Company”) on Form 10-K for the year ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James T. Hippel, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

       

 

 

 

 

/s/ James T. Hippel

 
 

James T. Hippel

Chief Financial Officer

August 26, 2020